Event Date and time: Wednesday 31st May, 2017 | 12:00 – 14:00
Venue details: Baker & McKenzie Ltd | 100 New Bridge Street | London EC4V 6JA
Organisers: Business Council for Africa
Event website: Africa’s Healthcare Market: Prospects and Projects
Event cost: £180
The healthcare sector in Africa is now estimated by the International Finance Corporation (IFC) to be worth $35bn per annum. There has been a sharp rise in demand for better quality healthcare from the growing middle class.
Despite the challenges of supply and distribution, the value of the African pharmaceutical market had climbed to $20.8bn in 2013, and Mckinsey expect it to reach approximately $US60bn by 2020. This event will be an opportunity to discuss the key drivers impacting the healthcare sector in Africa and answer the following questions:
- Big Pharmaceutical companies have radically changed their approach in recent years; how are the large pharmaceutical companies supporting the health system in Africa?
- Equity fund investment is on the rise; how does the financial sector assess risk and what are the key issues that are preventing investment into the sector?
- How can the government encourage the private sector to increase investment into the healthcare system in Africa?
- What are the future prospects of the healthcare industry in Africa?
- Bryan Pearson, Editor and Publisher, Africa Health
- Chris Bonnett, Project Development & Management Leader, GE Healthcare
- Gemma Gunn, Marketing Director, AstraZeneca
- Steven Raucher, Co-Founder, Rapid Deploy
- Saad Sheikh, Head of Portfolio Operations, TLG Capital
- Nick Oliver, Head of Business Development, NMS Infrastructure
BCA members should contact email@example.com for access code to receive their tickets without charge.